Jeroen C Jansen

16PUBLICATIONS
56CO-AUTHORS
Predictive and prognostic markersSensory systemsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 24, 2025
Textbook Outcome After Oral Cancer Surgery as a Composite Measure for Survival and Quality-of-Care Evaluation.

Hanneke Doremiek van Oorschot, Dominique Valerie Clarence de Jel, Jose Angelito Hardillo

|May 24, 2025
Validation of the prognostic model "oncologiq palliative" for head and neck cancer patients.

B N van den Besselaar, D van Klaveren, D Berzenji

|Feb 13, 2025
Efficacy and Toxicity of Bevacizumab in Children with NF2-Related Schwannomatosis: A Systematic Review.

Annemijn L Tops, Josefine E Schopman, Radboud W Koot

|Feb 13, 2025
Genetic Alterations in Patients with NF2-Related Schwannomatosis and Sporadic Vestibular Schwannomas.

Jules P J Douwes, Ronald van Eijk, Sybren L N Maas

|Dec 17, 2024
Postoperative Radiotherapy for pT1- and pT2-Classified Squamous Cell Carcinoma of the External Auditory Canal.

Cindy H Nabuurs, Wietske Kievit, Charles René Reinier Leemans

|Apr 27, 2024
Bevacizumab Treatment for Patients with NF2-Related Schwannomatosis: A Single Center Experience.

Jules P J Douwes, Erik F Hensen, Jeroen C Jansen

Pageof 3

Frequent Collaborators

9 joint publications

Erik F Hensen

3 joint publications

Olaf M Neve

3 joint publications

Jules P J Douwes

2 joint publications

Yunjie Chen